Search Results - "Jendrisak, Martin D"

Refine Results
  1. 1

    Virtual crossmatch by identification of donor-specific anti-human leukocyte antigen antibodies by solid-phase immunoassay: A 30-month analysis in living donor kidney transplantation by Morris, Gerald P, Phelan, Donna L, Jendrisak, Martin D, Mohanakumar, Thalachallour

    Published in Human immunology (01-03-2010)
    “…Abstract Selection of donors for kidney transplantation depends on accurate prediction of risk factors for immunologic rejection. Historically, cytotoxicity…”
    Get full text
    Journal Article
  2. 2

    Living donor renal transplantation in the presence of donor-specific human leukocyte antigen antibody detected by solid-phase assay by Phelan, Donna, Mohanakumar, T, Ramachandran, Sabarinathan, Jendrisak, Martin D

    Published in Human immunology (01-08-2009)
    “…Abstract Presensitization of donor human leukocyte antigens (HLA) demonstrated through a positive crossmatch is detrimental to allograft function and best…”
    Get full text
    Journal Article
  3. 3

    HLA class I antibody mediated accommodation of endothelial cells via the activation of PI3K/cAMP dependent PKA pathway by Narayanan, Kishore, Jendrisak, Martin D., Phelan, Donna L., Mohanakumar, T.

    Published in Transplant immunology (2006)
    “…Allografts transplanted across ABO incompatibility or human leucocyte antigen (HLA)-sensitization undergoes antibody (Ab) mediated hyperacute rejection…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Flow Cytometry Crossmatch Reactivity With Pronase-Treated T Cells Induced by Non-HLA Autoantibodies in Human Immunodeficiency Virus-Infected Patients by Szewczyk, Katarzyna, Barrios, Kelly, Magas, Daniel, Sieg, Kristin, Labuda, Bozena, Jendrisak, Martin D, Jaramillo, Andrés

    Published in Human immunology (01-06-2016)
    “…Abstract Pronase treatment is used in the flow cytometry crossmatch (FCXM) to prevent nonspecific antibody binding on B cells. However, we have observed…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Improving Syphilis Screening in Deceased Organ Donors by Theodoropoulos, Nicole, Jaramillo, Andrés, Penugonda, Sudhir, Wasik, Carol, Brooks, Katarzyna, Ladner, Daniela P, Jendrisak, Martin D, Ison, Michael G

    Published in Transplantation (01-02-2015)
    “…BACKGROUNDCurrent U.S. policy requires screening of all deceased organ donors for syphilis infection. To date, information on syphilis test performance in this…”
    Get full text
    Journal Article
  8. 8

    1014-LBP by Brooks, Katarzyna, Magas, Daniel, Sieg, Kristin, Carrera, Justin D, Labuda, Bozena, Jendrisak, Martin D, Jaramillo, Andres

    Published in Human immunology (01-06-2014)
    “…Aim Binding of IgG to FcR on B-cells decreases the sensitivity & specificity of the B-cell FCXM. To prevent this, pronase treatment (PT) of un-separated T- &…”
    Get full text
    Journal Article
  9. 9

    26-P by Sieg, Kristin, Magas, Daniel, Brooks, Katarzyna, Carrera, Justin D, Labuda, Bozena, Jendrisak, Martin D, Jaramillo, Andres

    Published in Human immunology (01-10-2012)
    “…Aim A positive crossmatch is considered a contraindication for kidney transplantation. Interestingly, we have observed a high rate of positive T-cell FCXM…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Prospective, Pilot, Open‐Label, Short‐Term Study of Conversion to Leflunomide Reverses Chronic Renal Allograft Dysfunction by Hardinger, Karen L., Wang, Candace D., Schnitzler, Mark A., Miller, Brent W., Jendrisak, Martin D., Shenoy, Surendra, Lowell, Jeffery A., Brennan, Daniel C.

    Published in American journal of transplantation (01-10-2002)
    “…Leflunomide (LEF) is a synthetic isoxazole derivative with anti‐inflammatory and antiviral properties, which has been reported to prevent acute rejection and…”
    Get full text
    Journal Article
  13. 13

    Hospital‐Independent Organ Recovery from Deceased Donors: A Two‐Year Experience by Jendrisak, Martin D., Hruska, Keith, Wagner, Jessica, Chandler, Dianne, Kappel, Dean

    Published in American journal of transplantation (01-05-2005)
    “…Early experience with deceased donor (DD) organ recovery outside of the hospital setting was found to be safe, efficient and cost effective. A 2‐year…”
    Get full text
    Journal Article
  14. 14

    Cadaveric-donor organ recovery at a hospital-independent facility by JENDRISAK, Martin D, HRUSKA, Keith, WAGNER, Jessica, CHANDLER, Diane, KAPPEL, Dean

    Published in Transplantation (15-10-2002)
    “…Of the many logistic issues addressed throughout the cadaveric organ donation process, timely access to the operating theater for surgical recovery of organs…”
    Get full text
    Journal Article
  15. 15

    Optimization of high-efficiency hemodialysis by detection and correction of fistula dysfunction by Windus, David W., Audrain, Jean, Vanderson, Rosie, Jendrisak, Martin D., Picus, Daniel, Delmez, James A.

    Published in Kidney international (01-08-1990)
    “…Optimization of high-efficiency hemodialysis by detection and correction of fistula dysfunction. Recirculation studies were performed in 103 patients treated…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    1014-LBP: Positive flow cytometry crossmatch results with pronase-treated t-cells induced by non-HLA autoantibodies in HIV-infected patients by Brooks, Katarzyna, Magas, Daniel, Sieg, Kristin, Carrera, Justin D., Labuda, Bozena, Jendrisak, Martin D., Jaramillo, Andres

    Published in Human immunology (01-06-2014)
    “…Binding of IgG to FcR on B-cells decreases the sensitivity & specificity of the B-cell FCXM. To prevent this, pronase treatment (PT) of un-separated T- &…”
    Get full text
    Journal Article
  19. 19

    26-P: FALSE-POSITIVE FLOW CYTOMETRY CROSSMATCH RESULTS WITH PRONASE-TREATED T-CELLS IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS by Sieg, Kristin, Magas, Daniel, Brooks, Katarzyna, Carrera, Justin D., Labuda, Bozena, Jendrisak, Martin D., Jaramillo, Andres

    Published in Human immunology (01-10-2012)
    “…A positive crossmatch is considered a contraindication for kidney transplantation. Interestingly, we have observed a high rate of positive T-cell FCXM results…”
    Get full text
    Journal Article
  20. 20